Braun Stacey Associates Inc. Lowers Position in Johnson & Johnson (JNJ)

Cornelia Mascio
Novembre 22, 2017

Ironwood Investment Management LLC now owns 5,074 shares of the company's stock valued at $671,000 after acquiring an additional 20 shares during the last quarter. Semtech Corp now has $2.58B valuation.

Shares of Johnson & Johnson (JNJ) traded up $0.41 during trading on Tuesday, reaching $138.34.

It's worth it to have a look at Johnson & Johnson (NYSE:JNJ) as there may be a chasm between the bulls and the bears as far as recent trading activity goes. It has outperformed by 55.59% the S&P500.

Capital City Trust Company decreased Johnson & Johnson (JNJ) stake by 5.84% reported in 2017Q2 SEC filing. Strategic Financial Services Inc acquired 2,963 shares as Johnson & Johnson (JNJ)'s stock rose 6.85%. Beck Mack & Oliver Llc who had been investing in Johnson & Johnson for a number of months, seems to be less bullish one the $371.65B market cap company. This is calculated by taking the earnings per share and dividing it by the last closing share price. Freestone Cap Holdings Lc holds 0.25% or 47,076 shares.

Johnson & Johnson (NYSE:JNJ) presently has a current ratio of 1.32. It has underperformed by 4.16% the S&P500. There were 51 sold out positions, on the other hand, totaling 2,267,926 shares. Ferguson Wellman Cap Management invested in 188,660 shares or 0.94% of the stock. Discovery Communications New (NASDAQ:DISCA) was raised too.

Among 8 analysts covering Immunogen (NASDAQ:IMGN), 5 have Buy rating, 1 Sell and 2 Hold. Therefore 14% are positive. Johnson & Johnson had 83 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has "Buy" rating by RBC Capital Markets on Monday, July 10. On Monday, October 9 the stock rating was upgraded by Wells Fargo to "Buy". The stock has "Neutral" rating by Atlantic Securities on Friday, December 18. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Seekingalpha.com and their article: "The Right Time To Buy Johnson & Johnson" published on November 17, 2017 as well as Seekingalpha.com's news article titled: "Johnson & Johnson: Dividend King With Good Total Return And Dividend Growth" with publication date: November 21, 2017. The rating was maintained by BMO Capital Markets with "Buy" on Tuesday, July 18. Jefferies maintained the shares of JNJ in report on Thursday, August 4 with "Hold" rating. Argus Research upgraded Johnson & Johnson (NYSE:JNJ) rating on Wednesday, July 20. Finally, Citigroup Inc. lifted their target price on shares of Johnson & Johnson from $140.00 to $149.00 and gave the company a "buy" rating in a research note on Monday, October 23rd. The company has a current ratio of 1.32, a quick ratio of 1.02 and a debt-to-equity ratio of 0.36. It increased, as 7 investors sold AT shares while 26 reduced holdings. 105 funds opened positions while 667 raised stakes.

The Earnings to Price yield of Johnson & Johnson (NYSE:JNJ) is 0.042353.

Johnson & Johnson (JNJ) saw 5.48 billion in free cash flow last quarter, representing a quarterly net change in cash of 3.12 billion. The Texas-based Texas Capital Financial Bank Tx has invested 0.97% in Johnson & Johnson (NYSE:JNJ). 1,417 are owned by Srb.

The Q.i. Value of Johnson & Johnson (NYSE:JNJ) is 33.00000. Monroe Bank Tru Mi invested 0.47% in Johnson & Johnson (NYSE:JNJ). Davidson Garrard owns 44,499 shares for 1.4% of their portfolio. Wade G W & holds 2.39% in Johnson & Johnson (NYSE:JNJ) or 142,630 shares. 4,470 were accumulated by Point72 Asia (Hong Kong) Limited. Snow Cap L P, a Pennsylvania-based fund reported 3,215 shares. Wallace Mgmt reported 2.25% stake. Millennium Limited Com invested in 0% or 644,676 shares. Smith Asset Group LP accumulated 89,560 shares. Panagora Asset has 0% invested in Semtech Corporation (NASDAQ:SMTC). They expect $1.72 EPS, up 8.86% or $0.14 from last year's $1.58 per share. After $1.90 actual EPS reported by Johnson & Johnson for the previous quarter, Wall Street now forecasts -9.47% negative EPS growth. For the full year, analysts expect earnings to decline -18.91% yoy to $4.63. C's profit will be $3.36 billion for 14.25 P/E if the $1.27 EPS becomes a reality. The company reported $1.90 earnings per share for the quarter, beating the consensus estimate of $1.80 by $0.10. The fund owned 43,000 shares of the company's stock after selling 10,000 shares during the quarter. The Business's subsidiaries operated 119 manufacturing facilities, as of January 1, 2017. Its the same as in 2017Q1. Virginia-based Thompson Davis Inc has invested 0.12% in Semtech Corporation (NASDAQ:SMTC). Meyer Handelman invested in 0.14% or 48,921 shares. Spectrum Management Group Inc holds 13,475 shares. Denver Investment Advsr reported 56,569 shares. Supplemental Annuity Collective Of Nj stated it has 41,143 shares. Fiduciary Of The Southwest Inc Tx reported 15,279 shares. Blackrock holds 5.38M shares. Goldman Sachs Grp Incorporated Inc owns 259,392 shares. Columbus Hill Mgmt Limited Partnership stated it has 36,000 shares. Truenorth Inc has 2,611 shares. Duncker Streett & Inc has 0.19% invested in Citigroup Inc (NYSE:C) for 9,094 shares. Sun Life Financial holds 21,315 shares or 0.3% of its portfolio. Fincl Engines Advsrs Ltd owns 13 shares or 0% of their United States portfolio.

Among 37 analysts covering Citigroup Inc. (NYSE:C), 19 have Buy rating, 3 Sell and 15 Hold. Therefore 63% are positive. Drexel Hamilton maintained the stock with "Buy" rating in Thursday, June 1 report. As per Wednesday, January 25, the company rating was maintained by RBC Capital Markets. The company was downgraded on Monday, September 21 by Morgan Stanley. The company was maintained on Wednesday, August 30 by Drexel Hamilton. The firm has "Buy" rating by B. Riley & Co given on Thursday, August 24. The rating was initiated by Societe Generale on Wednesday, April 6 with "Hold".

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE